Gut-brain axis: gut dysbiosis and psychiatric disorders in Alzheimer’s and Parkinson’s disease
Authors:
Open Access
- 13 November 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1268419
Abstract
Gut dysbiosis and psychiatric symptoms are common early manifestations of Alzheimer’s disease (AD) and Parkinson’s disease (PD). These diseases, characterised by progressive neuron loss and pathological protein accumulation, impose debilitating effects on patients. Recently, these pathological proteins have been linked with gut dysbiosis and psychiatric disorders. The gut-brain axis links the enteric and central nervous systems, acting as a bidirectional communication pathway to influence brain function and behavior. The relationship triad between gut dysbiosis, psychiatric disorders, and neurodegeneration has been investigated in pairs; however, evidence suggests that they are all interrelated and a deeper understanding is required to unravel the nuances of neurodegenerative diseases. Therefore, this review aims to summarise the current literature on the roles of gut dysbiosis and psychiatric disorders in pathological protein-related neurodegenerative diseases. We discussed how changes in the gut environment can influence the development of psychiatric symptoms and the progression of neurodegeneration and how these features overlap in AD and PD. Moreover, research on the interplay between gut dysbiosis, psychiatric disorders, and neurodegeneration remains in its early phase. In this review, we highlighted potential therapeutic approaches aimed at mitigating gastrointestinal problems and psychiatric disorders to alter the rate of neurodegeneration. Further research to assess the molecular mechanisms underlying AD and PD pathogenesis remains crucial for developing more effective treatments and achieving earlier diagnoses. Moreover, exploring non-invasive, early preventive measures and interventions is a relatively unexplored but important avenue of research in neurodegenerative diseases.Keywords
This publication has 183 references indexed in Scilit:
- Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar ratsJournal of Psychiatric Research, 2015
- The gut microbiota influences blood-brain barrier permeability in miceScience Translational Medicine, 2014
- Physical activity and risk of Parkinson’s disease in the Swedish National March CohortBrain, 2014
- Sodium Butyrate Prevents Memory Impairment by Re-establishing BDNF and GDNF Expression in Experimental Pneumococcal MeningitisMolecular Neurobiology, 2014
- Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviourNature Reviews Neuroscience, 2012
- Protein-Bound Uremic Toxins: New Insight from Clinical StudiesToxins, 2011
- Gut feelings: the emerging biology of gut–brain communicationNature Reviews Neuroscience, 2011
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2003
- Role of Escherichia coli Curli Operons in Directing Amyloid Fiber FormationScience, 2002
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991